title: Evaluation of the quinupristin/dalfopristin breakpoints for Enterococcus faecium.
authors.forename: Anette M
authors.initials: AM
authors.lastname: Hammerum
authors.forename: Yvonne
authors.initials: Y
authors.lastname: Agersø
authors.forename: Lourdes
authors.initials: L
authors.lastname: Garcia-Migura
authors.forename: Anne
authors.initials: A
authors.lastname: Mette Seyfarth
authors.forename: Lone J
authors.initials: LJ
authors.lastname: Porsbo
authors.forename: Hanne-Dorthe
authors.initials: HD
authors.lastname: Emborg
authors.forename: Lars
authors.initials: L
authors.lastname: Bogø Jensen
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D024901:Drug Resistance, Multiple, Bacterial; D016984:Enterococcus faecium / Q000187:drug effects*; D016908:Gram-Positive Bacterial Infections / Q000453:epidemiology / Q000382:microbiology / Q000662:veterinary*; D006801:Humans; D011201:Poultry Diseases / Q000453:epidemiology / Q000382:microbiology*; D013553:Swine Diseases / Q000453:epidemiology / Q000382:microbiology*; D014769:Virginiamycin / Q000008:administration & dosage*
chemical_list: D000900:Anti-Bacterial Agents; D014769:Virginiamycin; C062940:quinupristin-dalfopristin